Loading company…
Riskpilot
← Back to search
Sign in
Get full access
BRILLERIET NYT SYN HAMMEL ApS
APS
Active
CVR 30610490
Østergade 13
Retail sale of medical and orthopaedic goods · NACE 4774
Est. 2007
6 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2025
DKK 3,8M
+10% vs 2024
EBITDA margin
31.8%
+48% vs 2024
Equity ratio
72.5%
Financial strength
Net profit 2025
DKK 747K
+58% vs 2024
EBITDA — year on year
DKK millions
3M
2M
1M
1M
0M
2M
2021
1M
-50%
2022
1M
0%
2023
1M
0%
2024
1M
0%
2025
Key figures
Annual report 2025
Revenue
DKK 3,8M
+10%
EBITDA
DKK 1,2M
+48%
Net profit
DKK 747K
+58%
Total assets
DKK 3,6M
+14%
Equity
DKK 2,6M
+14%
Employees
6
—
Company information
Legal name
BRILLERIET NYT SYN HAMMEL ApS
CVR number
30610490
Legal form
Anpartsselskab
NACE code
4774 · Retail sale of medical and orthopaedic goods
Founded
2. juni 2007
Share capital
DKK 125.000
Employees
6 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af direktøren.
Company purpose
Selskabets formål er at drive optikerforretning og anden accessorisk virksomhed.
Contact
Address
Østergade 13
Phone
+4586961088
Email
brilleriet@mail.dk
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Retail sale of medical and orthopaedic goods
Companies in Favrskov
All Denmark companies
Revenue
DKK millions
0M
1M
3M
4M
6M
5M
2021
3M
2022
3M
2023
3M
2024
4M
2025
EBITDA
DKK millions
0M
1M
1M
2M
2M
2M
2021
1M
2022
1M
2023
1M
2024
1M
2025
Income statement
DKK thousands
Item
2021
2022
2023
2024
2025
Revenue
5.153
3.324
3.476
3.482
3.839
Staff expenses
-1.743
-2.073
-2.203
-2.159
-2.137
EBITDA
1.563
676
829
824
1.219
Depreciation & amort.
-176
-127
-139
-147
-140
EBIT
1.387
550
690
677
1.080
Net financials
-13
-13
-13
-61
-111
Profit before tax
1.375
536
677
616
969
Tax
310
133
164
145
222
Net profit
1.065
403
513
472
747
Balance sheet
DKK thousands
Item
2021
2022
2023
2024
2025
Total assets
3.209
2.623
2.799
3.134
3.558
Equity
2.343
1.846
1.985
2.256
2.578
Long-term debt
0
0
0
0
0
Short-term debt
853
774
814
878
980
Total debt
853
774
814
878
980
Financial ratios
5-year trend
EBITDA margin
31.8%
This company
15.8%
Market median
+101% vs market
2021
2025
Equity ratio
72.5%
This company
38.2%
Market median
+90% vs market
2021
2025
Return on equity
29.0%
This company
18.4%
Market median
+58% vs market
2021
2025
Net profit margin
19.5%
This company
8.1%
Market median
+141% vs market
2021
2025
Asset turnover
1.08×
This company
1.12×
Market median
+4% vs market
2021
2025
Debt / equity
0.38×
This company
0.62×
Market median
+39% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Current (1)
LL
Lise Lynge Nygaard Reese-Petersen
Management
Management
2007
Board of directors
Non-executive oversight
No data on file.
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
LYNGES HOLDING ApS
Company
100%
100%
2010
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
LYNGES HOLDING ApS
BRILLERIET NYT SYN HAMMEL ApS
(this company)
Board network connections
Board members of BRILLERIET NYT SYN HAMMEL ApS also hold positions in
0
other companies.
Person
Role here
Other companies
Lise Lynge Nygaard Reese-Petersen
Management
0 companies